DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Body JJ, Facon T, Coleman RE et al.
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
Clin Cancer Res 2006;
12: 1221-1228
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.